University of Texas MD Anderson Cancer Center Acquires Second Aushon Biosystems' 2470 Microarray Printer for its RPPA Core Facility  
7/27/2011 8:53:35 AM

BILLERICA, Mass.--(BUSINESS WIRE)--Aushon BioSystems, Inc., a leading provider of advanced microarray instrumentation and laboratory services for biomarker discovery, development and analysis announced today that the Department of Systems Biology at the MD Anderson Cancer Center has acquired another 2470 microarray printer from Aushon BioSystems. The new 2470 Arrayer will be utilized in the Cancer Center Support Grant (CCSG) Functional Proteomics Reverse Phase Protein Array (RPPA) Facility, a core facility that serves all researchers at MD Anderson Cancer Center, as well as other academic institutions and industries. Extremely high demand for RPPA data and the proven performance of the existing 2470 Arrayer helped drive the acquisition of the additional microarray printer. Combined with the current 2470 on-site, the ability of the Functional Proteomics RPPA Facility to meet the higher throughput demands for biomarker research and diagnostic testing on cancer patients’ protein pathways and drug reaction will be significantly expanded.